Imodium and Vivelle drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Imodium (loperamide hydrochloride) and Vivelle (estradiol). Common drug interactions include intestinal obstruction among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Imodium and Vivelle. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Imodium?

Imodium has active ingredients of loperamide hydrochloride. It is often used in diarrhea. eHealthMe is studying from 45,092 Imodium users. Check the latest studies of Imodium.

What is Vivelle?

Vivelle has active ingredients of estradiol. It is often used in hormone replacement therapy. eHealthMe is studying from 6,624 Vivelle users. Check the latest studies of Vivelle.



On Jul, 30, 2026

35 people who take Imodium and Vivelle together, and have interactions are studied.

Imodium and Vivelle drug interactions.

What are the common drug interactions of Imodium and Vivelle, by gender? *:

female:

  1. Intestinal obstruction
  2. Speech disorder
  3. Vision blurred
  4. Abdominal discomfort
  5. Arthralgia (joint pain)
  6. Erythema (redness of the skin)
  7. Hypersensitivity
  8. Cataract (clouding of the lens inside the eye)
  9. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  10. Coma (state of unconsciousness lasting more than six hours)

male:

  1. Fatigue (feeling of tiredness)
  2. Anaemia (lack of blood)
  3. Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
  4. Cardiomegaly (increased size of heart than normal)
  5. Cellulitis (infection under the skin)
  6. Central nervous system neoplasm (tumour of central nervous system)
  7. Clavicle fracture
  8. Contusion (a type of hematoma of tissue in which capillaries)
  9. Decreased appetite
  10. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

What are the common drug interactions of Imodium and Vivelle, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anal fissure
  2. Dyspepsia (indigestion)

50-59:

  1. Blood triglycerides increased
  2. Bone density decreased
  3. Breast cancer
  4. Breast disorder
  5. Breast mass
  6. Breast pain
  7. Bunion (a painful swelling on the first joint of the big toe)
  8. Cataract (clouding of the lens inside the eye)
  9. Coeliac disease (simple food intolerance)
  10. Colitis (inflammation of colon)

60+:

  1. Fatigue (feeling of tiredness)
  2. Dehydration (dryness resulting from the removal of water)
  3. Vomiting
  4. Weight decreased
  5. Anaemia (lack of blood)
  6. Aortic calcification (aortic calcification sign of heart valve disease)
  7. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  8. Atrioventricular block first degree (heart block first degree)
  9. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  10. Blood urea increased

What are the existing conditions these people have? *

  1. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 12 people, 34.29%
  2. Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 7 people, 20.00%
  3. Prostate Cancer: 6 people, 17.14%
  4. Abdominal Discomfort: 5 people, 14.29%
  5. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 11.43%
  6. Pain: 2 people, 5.71%
  7. Hot Flush (sudden feelings of heat): 2 people, 5.71%
  8. Hormone Level Abnormal: 2 people, 5.71%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 5.71%
  10. Gait Disturbance: 2 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Imodium and Vivelle?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Imodium and Vivelle:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Imodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vivelle:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Imodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vivelle and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on loperamide hydrochloride and estradiol (the active ingredients of Imodium and Vivelle, respectively), and Imodium and Vivelle (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: